HuCNS-SC® (human neural stem cells)

Our HuCNS-SC product candidate is a highly purified composition of human neural stem cells (tissue-derived or “adult” stem cells). HuCNS-SC cells are based on groundbreaking research conducted by StemCells scientists who, in 1999, were the first to identify by cell surface marker the human neural stem cell and to use monoclonal antibodies against the cell surface markers to prospectively isolate a highly purified, expandable population of neural stem cells from human brain tissue.

Prepared under controlled conditions and processed to cGMP standards, our HuCNS-SC cells are purified, expanded in culture, cryopreserved and then stored as “stem cells in a bottle,” ready to be transplanted as patient doses. The results of rigorous preclinical studies, including the transplantation of these cells in thousands of immunodeficient mice, have shown that our cells engraft, migrate, differentiate into the three major CNS cell types (neurons, astrocytes and oligodendrocytes), and possess the ability to survive long-term with no evidence of tumor formation or adverse effects.

Because the transplanted HuCNS-SC cells have been shown to engraft and survive long-term, this suggests the possibility for a durable clinical effect following a single transplantation. In January 2009, we completed the first clinical trial of our HuCNS-SC product candidate. Data from this first trial and from an ongoing observational study initiated following completion of the trial have demonstrated the initial clinical safety and tolerability of HuCNS-SC cells and the transplantation procedure. Additional data gathered in 2011 has shown that transplanted HuCNS-SC cells can persist even after immunosuppression has been discontinued. Learn more...

Differentiation of HuCNS-SC cells in transplanted mouse brain.

HuCNS Image
  • Neurons
  • Astrocytes
  • Oligodendrocytes

Patents

We hold 40 issued or allowed US and more than 100 foreign counterparts associated with our human neural stem cell technology, with broad claims covering composition of matter, methods and uses of these cells.

Learn more about our intellectual property…

Back to CNS Program main page…

Our HuCNS-SC product candidate is a highly purified population of human neural stem cells that are grown in suspension as clusters of cells called “neurospheres.” These cells can be expanded for a number of generations in culture while still retaining their potential to, at a single cell level, self-renew and differentiate into the three major cell types of the CNS – neurons, astrocytes and oligodendrocytes.

Current Target Indications

Our HuCNS-SC therapeutic product development program is addressing diseases and disorders in all three regions of the CNS – the brain, the spinal cord and the eye. Current target indications include:

Please Note!

You are about to open a web page or document that is hosted by a third party and is not maintained by StemCells, Inc. and to which our Privacy Policy does not apply.

This link is provided to you for convenience and does not serve as an endorsement by StemCells, Inc. of any information or contacts that you may find on this third party site.

Cancel | Continue

X